These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2619876)

  • 21. Processed antigen and MHC molecules.
    Cohen IR; Friedman A
    Prog Allergy; 1985; 36():190-202. PubMed ID: 3918313
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
    Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
    Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and stimulator cell requirements for generation and activation of minor histocompatibility antigen-specific memory cytotoxic T-lymphocyte precursors.
    Ando KI; Isobe KI; Hasegawa T; Iwamoto T; Ding RN; Rahman J; Muro Y; Yoshida T; Nagase F; Kawashima K
    Immunology; 1988 Aug; 64(4):661-7. PubMed ID: 2971608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I; Clark S; Henderson LA; Hood L; McMillan M; Forman J
    J Immunol; 1985 Sep; 135(3):2160-6. PubMed ID: 2410513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of class I MHC products in polyclonal activation of CTL function.
    Kane K; Clark WR
    J Immunol; 1984 Dec; 133(6):2857-63. PubMed ID: 6333449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathology of type 1 diabetes.
    Campbell IL; Harrison LC
    Mol Biol Med; 1990 Aug; 7(4):299-309. PubMed ID: 2233244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Falk K; Rötzschke O; Rammensee HG
    Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen presentation by liposomes: inhibition with antibodies.
    Walden P; Nagy ZA; Klein J
    Eur J Immunol; 1986 Jun; 16(6):717-20. PubMed ID: 3013642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
    Chen W; Ford MS; Young KJ; Zhang L
    Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure.
    Berkower I; Buckenmeyer GK; Berzofsky JA
    J Immunol; 1986 Apr; 136(7):2498-503. PubMed ID: 2419437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigen processing and antigen presentation by accessory cells of the immune system].
    Langner J
    Allerg Immunol (Leipz); 1985; 31(3):131-56. PubMed ID: 2416210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-presenting cell-T cell interaction in the chicken is MHC class II antigen restricted.
    Vainio O; Veromaa T; Eerola E; Toivanen P; Ratcliffe MJ
    J Immunol; 1988 May; 140(9):2864-8. PubMed ID: 3258887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.